SI
Silo Pharma, Inc.
SILO · NASDAQ
$1.72 -4.44% (-$0.08)
1M -32.17%
Market Cap $1.97M
P/E Ratio -
Div. Yield -
ROE 81.74%
Piotroski F-Score Weak
1/9Valuation
50 /100
Fair P/S 36.42x
P/B 0.40x
P/E N/A
Growth
16 /100
Declining Rev. growth 0.00%
Book val. growth 15.20%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 474.31%
Net margin 8,269.53%
Op. margin 8,250.46%
Quality
0 /100
Poor ROIC 91.31%
ROE 81.74%
ROA 75.13%
Debt
69 /100
Low Debt/Equity 0.00x
Current ratio 5.36x
Int. coverage -115.27x
Stability
76 /100
Stable Beta 0.75x
Rev. volatility 0.00%
EPS volatility 28.58%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o SILO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Eric Weisblum
Employees
3
Headquarters
Sarasota
Nadchodzące wydarzenia
02 GRU
Earnings
Upcoming earnings report